公司拥有“广东省蛋白质（多肽）分离纯化工程技术研究开发中心”、“广东省院士专家企业工作站”、“深圳市血液制品工程技术研究开发中心”、“深圳市基因重组类创新药物工程实验室”、“深圳市蛋白质（多肽）分离纯化公共技术服务平台”以及“博士后创新实践基地”等多个研发平台。
研发大楼配备了多功能微孔板检测系统、AKTA自动层析工艺优化系统、荧光定量PCR仪、高效液相色谱仪等研发及检测分析设备，中试配套硬件设施完善，构成了强有力的公司技术创新平台。
研发大楼配备了多功能微孔板检测系统、AKTA自动层析工艺优化系统、荧光定量PCR仪、高效液相色谱仪等研发及检测分析设备，中试配套硬件设施完善，构成了强有力的公司技术创新平台。
发展规划
development plan
gongsimiqieguanzhuguoneiwaizuixinkeyanchengguohexianjingongyiluxian，yishichanghezhengceweidaoxiang，yizishenxitongnengliweiyituo，guangfanduijieguonei、guojikeyanyuansuohechuangxinyanfaqiye，yichanpinjishuchuangxinweitupo，chixuzuoqiangxueyezhipinjishiyewu，chubuxingchenggongsichanpinchayihuajingzhengyoushi；tongshi，yiqianqiyimiaoxiangmuyanjiuweijichu，jiakuaibujuxinxingyimiaojishupingtai，peiyuqianzhanxingchanyexiangmu，xingchengyizizhukaifaweizhu，lianheyanfaweifudezhengheshiyanfamoshi。
“shisiwu”（2021-2025nian）xinzhanlveqinei，weiguangshengwujiangmiaozhunquanqiushengwuyiyaochanyedechuangxinzhigaodianhexianjinmoshi，shunyingchanyequshi，rongruquyufazhan，jiangu“guimoyulirun、suduyuzhiliang、duanqiyuzhangqi”sanduipingheng，shixianxueyezhipinyushengwuyiyao“shuanggui”bingjin。
创新成果
INNOVATIVE ACHIEVEMENTS
为鼓励支持研发创新，近五年公司研发总投入超两亿元，并制定了《科学创新奖励办法》、《对外科技成果转化项目奖励办法（试行）》等系列激励制度，提高了研发技术人员创新活力。公司内部定期开展“科技创新活动”，充分发挥员工自主能动性，搭建展示团队及个人创新能力的舞台，形成良好的创新氛围。
截至目前，
公司发表期刊论文及会议论文100余篇，
其中SCI文章11篇。
已拥有专利49项，
其中发明专利20项，
实用新型专利29项。
已获发明专利
| 序号 | 名称 |
|---|---|
| 1 | 人严重急性呼吸道症候群免疫球蛋白的分离提纯方法 |
| 2 | 静脉注射用人乙型肝炎免疫球蛋白制备方法 |
| 3 | 一种袋装冰血浆自动分拣机 |
| 4 | 静注巨细胞病毒人免疫球蛋白及其制备方法 |
| 5 | 人巨细胞病毒IgG抗体检测试剂盒和检测方法 |
| 6 | 狂犬病病毒CTN鸡胚细胞适应株 |
| 7 | 狂犬病病毒CTN-1株对原代鸡胚成纤维细胞的适应方法 |
| 8 | 一种静注人免疫球蛋白的制备方法 |
| 9 | 一种单组分TMB显色液及其制备方法 |
| 10 | 一种单组分TMB显色液的终止液及其制备方法 |
| 11 | 一种从组分IV-2沉淀中提取人血白蛋白的方法 |
| 12 | 一种人血浆载脂蛋白A#I的分离纯化方法 |
| 13 | 一种人血浆蛋白α1#抗胰蛋白酶的分离纯化方法 |
| 14 | 一种质粒DNA的产业化纯化方法及质粒DNA |
| 15 | 静注新型冠状病毒人免疫球蛋白的制备方法 |
| 16 | 一种质粒DNA原液制备方法 |
| 17 | 一种鸡胚细胞狂犬病病毒的生物反应器工艺 |
| 18 | 一种狂犬病疫苗灭活验证的试验方法 |
| 19 | 一种流感病毒疫苗血凝素含量测定方法及试剂盒 |
| 20 | 一种流感病毒裂解疫苗原液的制备方法 |
已发表SCI论文
| 序号 | 名称 |
|---|---|
| 1 | Liao Mingfeng,Liao Xuejiao,Yuan Jing,Zhou Bing,Liu Yang,Jiang Xiao,Zhang Zhan,Guo Caiping,Zhang Yunjia,Zhang Shuye,Liu Lei,Zhang Zheng. The concentrated antibody from convalescent plasma balanced the dysfunctional immune responses in patients with critical COVID‐19[J]. Clinical and Translational Medicine,2021,11(11): |
| 2 | Ji Qianqian,Guo Caiping,Xie Chen,Wu Yingdan,Zhang Pei,Li Hui,Lu Yongjun. Correction to: Genetically engineered cell lines for α1-antitrypsin expression.[J]. Biotechnology letters,2018,40(9-10): |
| 3 | Ji Qianqian,Guo Caiping,Xie Chen,Wu Yingdan,Zhang Pei,Li Hui,Lu Yongjun. Genetically engineered cell lines for α1-antitrypsin expression.[J]. Biotechnology letters,2017,39(10): |
| 4 | Shimao Zhu,Caiping Guo. Rabies Control and Treatment: From Prophylaxis to Strategies with Curative Potential[J]. Viruses,2016,8(11): |
| 5 | Caiping Guo(Corresponding author), Chunhua Wang, Shan Luo, Shimao Zhu, Hui Li, Yongdi Liu, Lanzhen Zhou, Pei Zhang, Xin Zhang, Yujiang Ding, Weirong Huang, Kaiyong Wu, Yanpeng Zhang, Weihua Rong, Hua Tian; The adaptation of a CTN-1 rabies virus strain to high-titered growth in chick embryo cells for vaccine development; Virology Journal 2014, 11（85），//www.virologyj.com/content/11/1/85, (SCI, IF: 2.092). |
| 6 | Caiping Guo, Kewein Liu, Haibo Luo, Hongbo Chen, Yi Zheng, Shengnan Sun, Qian Zhang, Laiqiang Huang. Potent Anti-tumor Effect Generated by a Novel Human Papillomavirus (HPV) Antagonist Peptide Reactivating the pRb/E2F Pathway. PLoS One. 2011; 6(3): e17734. (SCI, IF: 4.351) |
| 7 | Caiping Guo, Kewein Liu, Yi Zheng, Haibo Luo, Hongbo Chen, Laiqiang Huang. Apoptosis Induced by an Antagonist Peptide against HPV16 E7 in Vitro and in Vivo via Restoration of p53. Apoptosis. 2011; 16(6): 606-618; (SCI, IF: 4.066). |
| 8 | Hongbo Chen, Xiaomeng Shen, Caiping Guo, Hujun Zhu, Langzhen Zhou, Yongqiang Zhu, Hao Wang, Yi Zheng, Laiqiong Huang. Phosphatase and tensin homolog reconstruction and vascular endothelial growth factor knockdown synergistically inhibit the growth of glioblastoma. Cancer Biother Radiopharm. 2010; 25 (6): 713-21. (SCI, IF: 1.443) |
| 9 | Hongbo Chen, Lin Mei, Langzhen Zhou, Xudong Zhang, Caiping Guo, J Li, Hao Wang, Yongqiang Zhu, Yi Zheng, Laiqiang Huang. Moesin-ezrin-radixin-like protein (merlin) mediates protein interacting with the carboxyl terminus-1 (PICT-1)-induced growth inhibition of glioblastoma cells in the nucleus. Int J Biochem Cell Biol. 2011; 43 (4): 545-55. (SCI, IF: 4.887) |
| 10 | Hongbo Chen, Ling Mei, Langzhen Zhou, Xiaomeng Shen, Caiping Guo, Yi Zheng, Huijun Zhu, Yongqiang Zhu, L Huang. PTEN restoration and PIK3CB knockdown synergistically suppress glioblastoma growth in vitro and in xenografts. J Neurooncol. 2010. （SCI, IF: 2.903） |
| 11 | Zhan Zhang , Yiwu Xie, Jilin Hong, Xing Zhang. SARSIg Group. Purification of severe acute respiratory syndrome hyperimmune globulins for intravenous injection from convalescent plasma. Transfusion. 2005 Jul;45(7):1160-4.（SCI, IF:3.526） |